FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance-Reference-Cited by-同舟云学术

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

Published:2017-04-27 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Caratelli Sara,Sconocchia Tommaso,Arriga Roberto,Coppola Andrea,Lanzilli Giulia,Lauro Davide,Venditti Adriano,Del Principe Maria Ilaria,Buccisano Francesco,Maurillo Luca,Ferrone Soldano,Sconocchia Giuseppe

Funder

Associazione Italiana per la Ricerca sul Cancro

U.S. Department of Defense

National Cancer Institute

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity;Gross;Proc Natl Acad Sci U S A,1989

2. The promise and potential pitfalls of chimeric antigen receptors;Sadelain;Curr Opin Immunol,2009

3. Antitumor activity and long-term fate of chimeric antigen receptor positive T cells in patients with neuroblastoma;Louis;Blood,2011

4. Building better chimeric antigen receptors for adoptive T cell therapy;Bridgeman;Curr Gene Ther,2010

5. Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy;Ramos;Expert Opin Biol Ther,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broadening anticancer spectrum by preprocessing and treatment of T- lymphocytes expressed FcγRI and monoclonal antibodies for refractory cancers;Frontiers in Immunology;2024-06-17

2. Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies;Frontiers in Immunology;2024-06-03

3. Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma;Frontiers in Oncology;2024-04-22

4. Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review;Sensors;2023-12-15

5. Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20);Cancer Nanotechnology;2023-10-06